3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Ovarian Neoplasms
16
Endometrial Neoplasms
16
Breast Neoplasms
16
Triple Negative Breast Neoplasms
14
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Lung Neoplasms
13
Fallopian Tube Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
9
Neoplasm Metastasis
7
Carcinoma
5
Stomach Neoplasms
4
Neoplasms
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Peritoneal Neoplasms
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Ovarian Epithelial
3
Adenocarcinoma
3
Uterine Neoplasms
2
Urinary Bladder Neoplasms
2
Respiratory Tract Neoplasms
2
Pathologic Complete Response
2
Melanoma
2
Lung Diseases
2
Hypopharyngeal Neoplasms
2
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Paclitaxel
×
30 days
×
Clear all
No trials found.